Search

everythinglearnresearchcommunity

for

Search:↓

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

Second-generation antipsychotics offer no significant benefit over first-generation ones for schizophrenia.

Researchers found a specific T cell receptor linked to severe drug reactions like Stevens-Johnson syndrome when patients take carbamazepine.

Compound 3 protects the heart from damage by activating A1-adenosine receptors.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Certain drugs can reduce bladder muscle contractions, potentially helping treat bladder diseases.

New compounds similar to cromakalim were less effective at inhibiting insulin release but improved in solubility and one acted as a calcium entry blocker, not a potassium channel opener.

Potassium channel openers show promise for treating heart disease and other conditions, but more research is needed to fully understand their effects and safety.

Chloroquine and cinchonine relax rat blood vessels by affecting calcium channels, with chloroquine needing caution in heart patients.

Dyclonine can effectively reduce skin issues by inhibiting the TRPV3 channel.

2Br-Crebanine and Stephanine reduce inflammation and pain effectively.

Blocking certain brain processes reduces mating behavior in female rats.

Blocking GABA(A) receptors increases neuron sensitivity, showing GABA and glycine have different roles in pain.

Formyl-peptide receptor agonists could be new anti-inflammatory drugs.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Cepharanthine and tetrandrine show promise as COVID-19 drugs.

Astressin-B can reverse and prevent hair loss in stressed mice.

Cepharanthine may help treat COVID-19 by targeting multiple pathways.

CRH promotes fat production in skin cells, affecting conditions like acne.

Five preservatives may disrupt hormone function and need more health and environmental risk assessment.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

Adding a second method to PROTACs could improve cancer treatment.

Targeting NMMHC IIA may help treat blood-brain barrier damage.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

Changing the C-ring structure in certain compounds can make them better at blocking a specific human enzyme.

CB-03-04 shows promise as a treatment for prostate issues due to its strong anti-androgen effects.

Thyrotropin-releasing hormone may help control skin and hair growth and could aid in treating related disorders.

Testosterone reduces knee movement, while flutamide and finasteride increase it.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.